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rneuil’s disease: A case
port and literature review
fermedad de Verneuil. Presentación de un
so y  revisión de la  literatura
64-year-old  man  had  a  past  history  of  poorly  controlled
e  2  diabetes  mellitus  of  18-year  progression,  alcoholism,
d  severe  smoking.  He  presented  with  an  abscess  in  the
t  perianal  region  10  years  prior,  with  pain,  edema,  ery-
ma,  and  spontaneous  drainage  8  days  later;  at  present,
cording  to  the  patient,  symptoms  are  imperceptible  but
re  is  a  constant  scant  purulent  to  serous  discharge.
ysical  examination  revealed  irregular  widespread  involve-
nt  of  the  bilateral  gluteal,  perianal,  and  scrotal  areas,
th  the  presence  of  subcutaneous  nodules,  amorphous  and
egular  scars,  dermal  abscesses  with  secondary  ﬁbrosis,
uses  and/or  ulcers,  contracture,  and  induration  of  the
n  (Fig.  1).  No  anal  duct  involvement  was  identiﬁed  in
 proctologic  revision.  Laboratory  work-up  was  normal
d  culture  of  the  purulent  matter  reported  Escherichia
li.  Intra-anal  ultrasound  revealed  ‘‘ﬁstulous’’  tracts  with
 communication  with  the  anal  duct.  Surgical  treatment
s  radical  resection  of  the  complete  thickness  of  all  the
ected  skin  with  a  2  cm  margin  that  extended  to  the
cutaneous  fat,  leaving  only  healthy  tissue  (Fig.  2).
e  postoperative  period  was  satisfactory  and  the  patient
s  released  72  h  after  surgery,  with  only  sitz  baths  carried
t  for  the  secondary  wound,  and  follow-up  at  10  months
til  the  deﬁnitive  cure  and  release  (Figs.  3  and  4) with
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 recurrence,  no  infection,  and  with  epithelialization.  The
topathologic  study  reported  ‘‘hidradenitis  suppurativa’’.
Verneuil’s  disease  is  a  rare  pathology  of  unknown  eti-
gy.  The  ﬁrst  case  was  described  in  1839  by  Velpeau,
t  it  was  not  until  1854  that  it  was  clinically  identiﬁed
 Verneuil.1 It  is  characterized  by  nodular  inﬂammation
d  chronic  infection  of  the  apocrine  glands,  ‘‘ﬁstulas’’,ure  1  Hidradenitis  suppurativa  involving  the  bilateral
teal,  perianal,  and  scrotal  areas.
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Figure  2  Surgical  treatment  with  ample  resection,  debride-
ment,  and  bilateral  gluteal,  perianal,  and  scrotal  ﬁstulotomies.
abscesses,  and  ﬁbrosis  located  on  the  scalp,  neck,  axilla,
breast,  and  the  periumbilical,  inguinal,  perianal,  and  gluteal
regions.2
Its  incidence  is  1  in  every  600  individuals  and  it  is  more
frequent  in  men  and  in  adults.  It  is  associated  with  dia-
betes  mellitus,  overweight,  smoking,  anemia,  poor  hygiene,
hormone  disorders,  and  Cushing’s  disease.3,4 Symptoms  are:
a  minimum  of  pain,  continuous  scant  purulent  discharge,
and  edema  and  erythema  in  the  affected  zone;  there  is  no
systemic  inﬂammatory  data,  but  the  pathology  has  a  neg-
ative  psychologic  and  social  effect.5 The  most  frequently
isolated  microorganisms  are:  Proteus  mirabilis,  Staphylo-
coccus  aureus, and  Escherichia  coli.6 Diagnosis  is  difﬁcult
if  there  is  no  experience  with  the  disease,  and  therefore
it  tends  to  become  chronic  and  extend  from  the  involved
area.7
Figure  4  Progression  at  5  months  with  100%  cicatrization.
The  concept  of  hidradenitis  suppurativa  is  not  new,  but
its  etiology  is  unknown,8 and  so  the  following  was  concluded
upon  analyzing  the  present  case:
The  origin  of  this  pathology  comes  from  a  poorly  drained
abscess2,9 that  remains  in  the  subcutaneous  zone  and
extends  toward  the  epithelium,  where  it  converges  with  the
apocrine  glands,  becoming  chronic  in  a  poorly  vascularized
zone.
Morphologically,  the  ﬁstulas  are  paradoxical,  superﬁcial,
multiple,  and  they  are  communicated  with  each  other  and
irregular,  with  no  common  origin  or  epithelium;  they  do
not  reach  the  status  of  a  classic  ﬁstula  (deﬁning  ﬁstula  as
an  opening  or  passage  that  exists  from  one  epithelium  to
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eFigure  3  Favorable  progression  at  3  months  with  no  infectious
process  of  the  granulated  tissue.another).
It  is  a  chronic  disease  with  no  clinical  systemic  man
ifestation,  it  is  not  incapacitating,  and  in  some  cases  
painless,10 due  to  a  high  degree  of  adaptability  or  of  becom
ing  accustomed  to  it;  the  loss  of  anatomy  and  its  consequen
physiology  results  in  destroyed  or  very  damaged  nociceptor
Another  contributing  factor  is  diabetic  neuropathy.
Treatment  with  oral  and  topical  antibiotics  (clindamycin
tetracyclines,  metronidazole,  cephalosporins,  rifampicin
etc.)  and  the  purely  topical  ones  (resorcinol,  fusidic  acid
azelaic  acid)  is  described,  all  with  high  recurrences.  Sy
temic  corticoids  (cyclosporine,  azathioprine,  methotrexate
alpha  TNF  inhibitors,  including  inﬂiximab)  provide  di
creet  improvement  and  transitory  results.  Antiandrogen
(cyproterone  acetate,  ﬁnasteride,  ethinyl  estradiol)  hav
very  limited  results.  Patients  worsen  with  zinc  salts.  Or
retinoids  (isotretinoin,  acitretin)  provide  minimum  improve
ment.  Radiotherapy,  cryotherapy,  photodynamic  therap
botulinum  toxin,  and  radiofrequency  have  all  shown  ve
poor  results.2,8,9
Pharmacologic  treatment  is  not  an  option,  due  to  th
diminished  vascularity  of  the  area  and  the  continuous
chronic  inﬂammation  process.  Therefore,  the  only  choice
left  is  surgery  and  the  technique  is:  radical  resection  with
disease-free  borders  and  closure  by  secondary  intention.
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The  gluteal  and  perianal  area,  in  particular,  has  late
cicatrization.  Nevertheless,  secondary  wound  closure  is  an
excellent  alternative  even  in  immunosuppressed  patients.
Deformation  is  acceptable  and  there  is  no  limitation  in  the
function  of  the  anatomic  region  in  question.  Sitz  baths  as  a
therapeutic  measure  make  it  possible  to  avoid  a  second  sur-
gical  procedure,  such  as  ﬂap  rotation  or  graft  application,
given  that  it  is  an  extensive  bloody  or  denuded  area  that  is
very  painful,  with  a  high  risk  for  infection  or  recurrence  and
prolonged  cicatrization.
Sitz  baths  provide  adequate  pain  and  inﬂammation  con-
trol,  reducing  analgesic  consumption,  and  cicatrization  is
improved  with  granulated  tissue,  preventing  infection  and
recurrence.  And  it  is  a  low-cost  outpatient  procedure.
In  conclusion,  the  presentation  of  this  case  (there  is
no  protocol  treatment  to  date)  is  a  ‘‘watershed’’  for  the
basis  of  new  studies  that  deﬁne  the  disease  pathophysiology,
treatment,  and  its  cure.
Verneuil’s  disease  is  of  great  interest  to  the  medical
community  and  merits  interdisciplinary,  comprehensive,  and
long-term  management.
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